MedTrace Logo

Septic cArdiac Deficiency and MenIngococcal seveRe Sepsis

NCT02041663 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2023-08-28

No results posted yet for this study

Summary

Use of brain natriuretic peptide to evaluate the cardiac function in the course of meningococcal septic shock or severe sepsis.

Conditions

  • Meningococcal Infections
  • Septic Shock
  • Severe Sepsis

Interventions

BIOLOGICAL

BNP

Repeated brain natriuretic peptide dosages and cardiac echographies up to day 5

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Jean Bergougnoux, MD · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-05
Primary Completion
2018-07-11
Completion
2018-07-11

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02041663 on ClinicalTrials.gov